183 related articles for article (PubMed ID: 5300283)
21. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
Utkin VV; Rudoĭ NM
Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
[No Abstract] [Full Text] [Related]
22. [A comparison of the effects of the combined therapy with CPM+1321 TH+CS, KM+1321 TH+CS and KM+1314 TH+CS in the treatment of pulmonary tuberculosis].
Iizuka Y; Iwasaki T; Fujioka K
Kekkaku; 1969 Mar; 44(3):109-15. PubMed ID: 5783307
[No Abstract] [Full Text] [Related]
23. [Endocavernous treatment of caverns with atypical Mycobacteria].
Neef W
Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
[No Abstract] [Full Text] [Related]
24. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
Tsukamura M
Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
[No Abstract] [Full Text] [Related]
25. [Evaluation of the therapeutic effects of secondary antitubercular agents].
Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
[No Abstract] [Full Text] [Related]
26. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
Wagner J
Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
[No Abstract] [Full Text] [Related]
27. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
Ivanova ES; Komarova AA
Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
[No Abstract] [Full Text] [Related]
28. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
[No Abstract] [Full Text] [Related]
29. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis].
Ivanova ES
Antibiotiki; 1967 Aug; 12(8):727-32. PubMed ID: 4968419
[No Abstract] [Full Text] [Related]
30. [Treatment of chronic destructive pulmonary tuberculosis by intravenous injections of morphazinamide].
Utkin VV; Zankisova IG; Polishchuk AK; Krylova NP; Gridneva SM
Vrach Delo; 1972 Feb; 2():57-8. PubMed ID: 5084744
[No Abstract] [Full Text] [Related]
31. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
[No Abstract] [Full Text] [Related]
32. Intermittent chemotherapy.
Tubercle; 1967 Mar; 48(1):58-61. PubMed ID: 4166513
[No Abstract] [Full Text] [Related]
33. [On therapeutic effects of morphazinamide, used alone and in association, in recent and chronic pulmonary tuberculosis].
Pasargiklian M
Minerva Med; 1965 Sep; 56(71):2855-62. PubMed ID: 5322267
[No Abstract] [Full Text] [Related]
34. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
[No Abstract] [Full Text] [Related]
35. [Clinical problems of resistance to secondary antitubercular agents].
Baba H; Takahashi R; Nakai T; Torii R; Yo I
Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
[No Abstract] [Full Text] [Related]
36. Preclinical Development of Inhalable d-Cycloserine and Ethionamide To Overcome Pharmacokinetic Interaction and Enhance Efficacy against
Ranjan R; Srivastava A; Bharti R; Roy T; Verma S; Ray L; Misra A
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962335
[TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy effectiveness in destructive pulmonary tuberculosis in the middle-aged and elderly using different methods of administering the preparations].
Abrarov BA; Tursunov FI; Leĭbzon IuN; Slobodskoĭ SA; Arifov SA
Probl Tuberk; 1982 Mar; (3):34-7. PubMed ID: 7088920
[No Abstract] [Full Text] [Related]
38. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
[No Abstract] [Full Text] [Related]
39. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
Malinowska B; Pawlak F
Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
[No Abstract] [Full Text] [Related]
40. [Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):199-200. PubMed ID: 555425
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
